deCODE genetics
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
- Specialty Pharmaceuticals
- Digital Health
- Disease Management
Latest on deCODE genetics
Amgen, Inc. chief technology officer David Reese, who recently handed over his prior title of EVP of research and development to Jay Bradner, explained in an interview with Scrip during this month’
R&D leaders from Amgen, Inc. , Johnson & Johnson and Takeda Pharmaceutical Co. Ltd. deliberated, at a recent summit, the potential of big data to uncover biological insights and complex issues ar
Amgen, Inc. acknowledged during its business review on 8 February that drug pricing and competitive pressures are growing hurdles for the biopharmaceutical industry through the end of this decade. As
The biggest question going into the J.P. Morgan Healthcare Conference every year is which big company is going to announce a large acquisition. Amgen, Inc. CEO Robert Bradway’s answer on 11 January